Tag: Alzheimer’s Disease
Firms guide Fosun Pharma’s option agreement with AriBio
HSF, Kewei and Goodwin advise Fosun Pharma on USD240 million AriBio Alzheimer’s drug agreement
HSF, Kewei and Goodwin advise Fosun Pharma on USD240 million AriBio Alzheimer’s drug agreement
Chris Parsons shares his reflections on the Indian legal market’s transformation from 2005 to 2025
Follow us on LinkedIn